Prolymphocytic leukemia (Q68502393)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

review article

1 reference

title

Prolymphocytic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

Stone RM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 April 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

457-471

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

Prolymphocytic leukemia: clinical, histopathological, and cytochemical observations

24 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Investigation of a new parameter in chronic lymphocytic leukemia: the percentage of large peripheral lymphocytes determined by the Hemalog D. Prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Increase in T gamma lymphocytes in B-cell chronic lymphocytic leukaemia. II. Correlation with clinical stage and findings in B-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

T-cell leukaemias with "helper" phenotype in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukaemia of B and T cell type.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

The membrane phenotype of T-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Cytoplasmic inclusions in a case of prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukaemia: an ultrastructural study of 22 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Interferon and B-cell prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

'Prolymphocytoid' cells in chronic lymphocytic leukaemia and their prognostic significance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Successful remission induction with deoxycoformycin in elderly patients with T-helper prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

‘Prolymphocytoid’ Transformation of Chronic Lymphocytic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Richter's syndrome in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Acute lymphocytic leukemic transformation of chronic lymphocytic leukemia: substantiation by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chromosomal aberrations in chronic B-cell lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic transformation of chronic lymphocytic leukemia. A report of three cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Acute tumor lysis syndrome in prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Fulminant leukemic polyradiculoneuropathy in a case of B-cell prolymphocytic leukemia. A clinicopathologic report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Treatment of prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Interferon response in B-cell prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukemia. An ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic transformation of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

T-cell prolymphocytic leukemia with an unusual phenotype CD4+ CD8+

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Efficacy of doxorubicin in prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Complete remission in prolymphocytic leukemia with 4-demethoxydaunorubicin and arabinosyl cytosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

The histopathology of prolymphocytic leukaemia with particular reference to the spleen: a comparison with chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chronic T-cell leukaemias. A variant of T-prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prognosis in T prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

The morphological spectrum of T-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of 'prolymphocytoid' transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. IV. Analysis of survival and prognostic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Complete remission in T-cell prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Splenic irradiation in B-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Interleukin-2 can induce proliferation of leukemic B-cells in prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Right heart obstruction due to intracavitary prolymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chromosome abnormalities in B-cell prolymphocytic leukemia: a study of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chronic T-cell leukemias. II. Cytogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukaemia: surface morphology in 21 cases as seen by scanning electron microscopy and comparison with B-type CLL and CLL in 'prolymphocytoid' transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Thymic irradiation in T-cell prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Intracytoplasmic inclusions in B prolymphocytic leukaemia: ultrastructural, cytochemical, and immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukemia treated by leukapheresis with relief of respiratory symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Complete remission in prolymphocytic leukaemia with the combination chemotherapy---CHOP

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

A preliminary study of low-dose splenic irradiation for the treatment of chronic lymphocytic and prolymphocytic leukaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukemia. Serial responses to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukemia with IgM hypogammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

T-cell prolymphocytic leukemia with helper-cell phenotype and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

T-cell prolymphocytic leukemia. Clinical and immunologic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

Chronic lymphocytic leukemia terminating in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2818%2930498-2

7 January 2021

10.1016/S0889-8588(18)30498-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2182602%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference